UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

The cole midfoot osteotomy: a retrospective review of 11 procedures in 8 patients

The Journal of foot and ankle surgery, 2004-05, Vol.43 (3), p.160-165

2004

Volltextzugriff (PDF)

Physeal fractures of the ankle

Clinics in podiatric medicine and surgery, 1999-10, Vol.16 (4), p.793-812

1999

Volltextzugriff (PDF)

Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesis

Genome research, 2014-05, Vol.24 (5), p.733

2014

Volltextzugriff (PDF)

Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic

Cell, 2021-09, Vol.184 (18), p.4651-4668.e25

2021

Volltextzugriff (PDF)

Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment

The lancet respiratory medicine, 2013-08, Vol.1 (6), p.462-470

2013

Volltextzugriff (PDF)

Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic

Cell, 2024-03, Vol.187 (6), p.1565-1566

2024

Volltextzugriff (PDF)

The molecular bacterial load assay replaces solid culture for measuring early bactericidal response to antituberculosis treatment

Journal of clinical microbiology, 2014-08, Vol.52 (8), p.3064-3067

2014

Volltextzugriff (PDF)

Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients

Journal of antimicrobial chemotherapy, 2015-05, Vol.70 (5), p.1558-1566

2015

Volltextzugriff (PDF)

Evaluation of a novel cardioversion intervention for atrial fibrillation: the Ottawa AF cardioversion protocol

Europace (London, England), 2019-05, Vol.21 (5), p.708-715

2019

Volltextzugriff (PDF)

Medical Issues in American Football: Eyes, Teeth, and Skin

The American journal of orthopedics (Belle Mead, N.J.), 2016-09, Vol.45 (6), p.377

2016

Volltextzugriff (PDF)

Discovery and in Vivo Evaluation of Dual PI3Kβ/δ Inhibitors

Journal of medicinal chemistry, 2012-09, Vol.55 (17), p.7667-7685

2012

Volltextzugriff (PDF)

Direct Comparison of Xpert MTB/RIF Assay with Liquid and Solid Mycobacterial Culture for Quantification of Early Bactericidal Activity

Journal of Clinical Microbiology, 2013-06, Vol.51 (6), p.1894-1898

2013

Volltextzugriff (PDF)

Imidazo-pyrazine derivatives as potent CXCR3 antagonists

Bioorganic & medicinal chemistry letters, 2009-09, Vol.19 (17), p.5200-5204

2009

Volltextzugriff (PDF)

Erratum to: The 2016 Thermal Spray Roadmap

Journal of thermal spray technology, 2017, Vol.26 (5), p.985-986

2017

Volltextzugriff (PDF)

Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38α inhibitor: identification of an active metabolite in preclinical species and human liver microsomes

Biopharmaceutics & drug disposition, 2006-11, Vol.27 (8), p.371-386

2006

Volltextzugriff (PDF)

Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes

Biopharmaceutics & drug disposition, 2006-11, Vol.27 (8), p.371

2006

Volltextzugriff (PDF)

Preclinical pharmacokinetics and metabolism of 6-(4-(2,5- difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyr idine , a novel and selective p38 alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes

Biopharmaceutics & drug disposition, 2006-01, Vol.27 (8), p.371-386

2006

Volltextzugriff (PDF)

Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3 -isopropyl -[1,2,4 ] -triazolo [4,3-a] pyridine, a novel and selective p38a inhibitor : Identification of an active metabolite in preclinical species and human liver microsomes

Biopharmaceutics & drug disposition, 2006, Vol.27 (8), p.371-386

2006

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(21)
Buchkapitel
(1)

Sprache

Englisch
(22)
Japanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

The cole midfoot osteotomy: a retrospective review of 11 procedures in 8 patients

Physeal fractures of the ankle

Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesis

The 2016 Thermal Spray Roadmap

Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic

Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment

Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic

The molecular bacterial load assay replaces solid culture for measuring early bactericidal response to antituberculosis treatment

Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients

Evaluation of a novel cardioversion intervention for atrial fibrillation: the Ottawa AF cardioversion protocol

Medical Issues in American Football: Eyes, Teeth, and Skin

Discovery and in Vivo Evaluation of Dual PI3Kβ/δ Inhibitors

A brain penetrant progranulin biotherapeutic rescues lysosomal and inflammatory phenotypes in the brain of GRN knockout mice

A brain penetrant progranulin biotherapeutic rescues lysosomal and inflammatory phenotypes in the brain of GRN knockout mice: Lipids in AD and FTD: From genes to interventions

Direct Comparison of Xpert MTB/RIF Assay with Liquid and Solid Mycobacterial Culture for Quantification of Early Bactericidal Activity

Imidazo-pyrazine derivatives as potent CXCR3 antagonists

Erratum to: The 2016 Thermal Spray Roadmap

Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38α inhibitor: identification of an active metabolite in preclinical species and human liver microsomes

Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes

Preclinical pharmacokinetics and metabolism of 6-(4-(2,5- difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyr idine , a novel and selective p38 alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes

Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3 -isopropyl -[1,2,4 ] -triazolo [4,3-a] pyridine, a novel and selective p38a inhibitor : Identification of an active metabolite in preclinical species and human liver microsomes

Contributor contact details

Suchergebnisse filtern